Timed cerebellar stimulation with immersive virtual reality to boost social prediction
Official title: Spatiotemporal Entrainment as Innovative Neuromodulation Targeting Cerebello-cerebral Circuits for Enhancing Rehabilitation Outcomes of Cognitive and Social Skills in Progressive and Acquired Cerebellar Diseases
Run by LIFE - Research and Care Institute - Santa Lucia IRCCS · NCT07500103 · Data updated 2026-11-12
This trial will try personalized cerebellar HD-tACS together with immersive virtual reality to improve social prediction in adolescents and young adults with congenital cerebellar malformations and in adults with degenerative cerebellar atrophy.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 12 Years and up |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | LIFE - Research and Care Institute - Santa Lucia IRCCS Academic / other |
| Locations | 2 sites (Pavia and 1 other locations) |
| Status | Recruiting |
| Started | January 15, 2025 |
| Main results expected | February 2027 |
| Study ends | April 2027 |
| Registry record updated | March 30, 2026 |
| Trial ID | NCT07500103 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are people aged 12–32 with congenital cerebellar malformations (IQ ≥50) or adults with degenerative cerebellar atrophy (IQ ≥75) who have predominantly cerebellar damage, intact enough motor/visual function to perform the tasks, and no contraindications to tACS.
✕Probably not a fit
Patients with extra-cerebellar lesions, severe motor or visual impairments, diagnosed autism or other neurodevelopmental/psychiatric conditions that would prevent task participation, or any contraindication to tACS are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a randomized, double-blind, sham-controlled trial run in two clinical cohorts (30 patients with congenital cerebellar malformations and 30 with degenerative cerebellar atrophy). Participants receive eight consecutive daily 1-hour immersive virtual reality sessions targeting social prediction while simultaneously receiving either EEG-guided active High-Definition transcranial Alternating Current Stimulation (HD-tACS) to the cerebellum or sham stimulation. Allocation is 1:1 active versus sham using computer-generated blocked randomization with blinding of participants and assessors. Outcomes are measured at baseline, immediately after the 8-day intervention, and at a two-month follow-up to examine short- and medium-term effects.
Why it matters
Potential benefit: If successful, the approach could improve patients' ability to anticipate others' intentions and enhance everyday social interactions.
How similar studies have gone: Small prior studies suggest cerebellar neuromodulation and virtual-reality training can alter networks and improve some cognitive functions, but the combined EEG-guided HD-tACS plus immersive social VR approach in cerebellar patients is largely novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria for patients with cerebellar malformation include: * Documented malformations confined to the cerebellum confirmed by a 3T brain MRI scan; * Age ranging from 12 to 32 years old; * IQ \>= 50; * Absence of extra-cerebellar malformations on conventional brain MRI scan. Inclusion Criteria for patients with degenerative cerebellar atrophy include: * Evidence of diffuse cerebellar atrophy; * More than 6 months of illness; * IQ \>=75; * Absence of any cortical lesion on conventional brain MRI scans Exclusion Criteria for both groups include: * Presence of severe motor and visual impairments, as well as neurodevelopmental (i.e., autism), neurological or psychiatric disorders that could interfere with task execution and protocol compliance; * Presence of any contraindication for tACS.
Where it's running
-
IRCCS National Neurological Institute "C. Mondino" Foundation
Pavia, Italy Recruiting -
I.R.C.C.S. Fondazione Santa Lucia
Roma, Italy Not yet recruiting
Study contacts
- Principal investigator: Maria Leggio, MD, PhD — I.R.C.C.S. Fondazione Santa Lucia
- Study coordinator: Maria Leggio, MD, PhD
- Email: m.leggio@hsantalucia.it
- Phone: +39 06 49917645
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Variable Intense Training for Ataxia and Locomotion
This study tests whether a high-intensity stepping program in variable contexts helps people with cerebellar disorders improve walking more than conventional balance training.
-
Manual Therapy Before Neuromotor Rehab in Children with Cerebral Palsy
In this pilot study, researchers test whether 30 minutes of lower-limb manual therapy before functional neuromotor therapy helps improve gait and motor performance in children with spastic cerebral palsy.
-
Gentle Touch therapy for arm lymphedema after breast cancer surgery
We will test whether adding Gentle Touch lymphatic drainage to usual rehabilitation reduces arm swelling in women aged 30–75 with breast cancer–related lymphedema.
-
Personalized non-invasive magnetic and electrical stimulation of memory networks in mild Alzheimer's
This study will try a personalized combination of magnetic (iTBS) and electrical (tACS) non-invasive brain stimulation to improve memory and brain connectivity in people with mild Alzheimer's disease.
-
EMG-controlled virtual hand with cerebellar magnetic stimulation to improve arm recovery after stroke
This program will test whether an EMG-controlled virtual reality hand combined with brief cerebellar magnetic stimulation helps adults (18–79) with mild-to-moderate upper-limb weakness after a first ischemic stroke regain reaching ability and arm function.
-
Device for early detection of Alzheimer's disease using eye imaging
This study is testing a new eye imaging device to see if it can help detect Alzheimer's disease early in people aged 55 and older.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.